Efficacy and Tolerability of Selective Internal Radiotherapy With Yttrium-90 as Consolidation Treatment After Chemotherapy in Metastatic Colorectal Cancer.

[1]  V. Gebski,et al.  First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials , 2017, The Lancet. Oncology.

[2]  T. Treasure,et al.  Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial , 2017 .

[3]  V. Gebski,et al.  Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer , 2017, JMIR research protocols.

[4]  V. Gebski,et al.  SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  A. Russo,et al.  Multisciplinary management of patients with liver metastasis from colorectal cancer. , 2016, World journal of gastroenterology.

[6]  Robert C. G. Martin,et al.  Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy , 2016, Journal of surgical oncology.

[7]  B. Sangro,et al.  Selective internal radiation therapy (SIRT) using Y90 resin microspheres as consolidation treatment for liver metastases from colorectal cancer (LCRC). , 2015 .

[8]  A. Corvalán,et al.  Identification of novel upregulated microRNAs in the pathogenesis of gastric cancer by the use of open access databases and bioinformatics tools. , 2015 .

[9]  Ricky A. Sharma,et al.  FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal ca , 2014, BMC Cancer.

[10]  P. Gibbs,et al.  A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases , 2014, Journal of Cancer Research and Clinical Oncology.

[11]  I. Nagtegaal,et al.  Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. , 2014 .

[12]  M. Peeters.  Future directions for selective internal radiation therapy in colorectal cancer , 2012 .

[13]  T. Gruenberger,et al.  Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients , 2009, Journal of surgical oncology.

[14]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Altendorf-Hofmann,et al.  Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.

[16]  M. Unno,et al.  Colorectal Liver Metastases: A Critical Review of State of the Art , 2016, Liver Cancer.

[17]  J. Wong,et al.  Local Ablation for Solid Tumor Liver Metastases: Techniques and Treatment Efficacy. , 2016, Cancer control : journal of the Moffitt Cancer Center.